Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Oracle Corporation (ORCL) A Good Stock To Buy?

Page 1 of 2

Is Oracle Corporation (NYSE:ORCL) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy league graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of news stories covering failed hedge fund investments (for some reason media paid a ton of attention to Ackman’s gigantic JC Penney and Valeant failures) and it is a fact that hedge funds’ picks don’t beat the market 100% of the time, but their consensus picks have historically done very well and have outperformed the market after adjusting for risk.

Is Oracle Corporation  the right investment to pursue these days? The best stock pickers are taking a slightly bearish view. The number of bullish hedge fund bets decreased by 1 in recent months. ORCL was in 57 hedge funds’ portfolios at the end of the third quarter of 2015. There were 58 hedge funds in our database with ORCL holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Visa Inc (NYSE:V), Royal Dutch Shell plc (ADR) (NYSE:RDS), and Citigroup Inc. (NYSE:C) to gather more data points.

Follow Oracle Corp (NYSE:ORCL)
Trade (NYSE:ORCL) Now!

If you’d ask most market participants, hedge funds are viewed as slow, outdated financial tools of the past. While there are more than 8000 funds trading at present, Our researchers choose to focus on the top tier of this club, approximately 700 funds. These money managers preside over most of the smart money’s total capital, and by tailing their best stock picks, Insider Monkey has identified many investment strategies that have historically surpassed the market. Insider Monkey’s small-cap hedge fund strategy outpaced the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

Keeping this in mind, we’re going to go over the latest action surrounding Oracle Corporation (NYSE:ORCL).

How are hedge funds trading Oracle Corporation (NYSE:ORCL)?

At the end of the third quarter, a total of 57 of the hedge funds tracked by Insider Monkey were long this stock, a change of -2% from the second quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of noteworthy hedge fund managers who were upping their holdings substantially (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Eagle Capital Management, managed by Boykin Curry, holds the largest position in Oracle Corporation (NYSE:ORCL). Eagle Capital Management has a $1.575 billion position in the stock, comprising 6.9% of its 13F portfolio. Coming in second is Yacktman Asset Management, managed by Donald Yacktman, which holds a $952.1 million position; 6.2% of its 13F portfolio is allocated to the company. The remaining members of the smart money with similar optimism consist of Robert Rodriguez and Steven Romick’s First Pacific Advisors LLC, Ken Fisher’s Fisher Asset Management and Richard S. Pzena’s Pzena Investment Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!